The society of thoracic surgeons practice guideline series: Aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)

Annals of Thoracic Surgery

Volumn 79, Issue 4, 2005, Pages 1454-1461

  Ferraris, Victor A ^a   Ferraris, Suellen P ^b   Moliterno, David J ^b   Camp, Philip ^b   Walenga, Jeanine M ^b   Messmore, Harry L ^b   Jeske, Walter P ^b   Edwards, Fred H ^b   Royston, David ^b   Shahian, David M ^b   Peterson, Eric ^b   Bridges, Charles R ^b   Despotis, George ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR BLOCKING AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; HIRUDIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBIN INHIBITOR; TICLOPIDINE; TIROFIBAN; WARFARIN;

CLINICAL TRIAL; CORONARY ARTERY RECANALIZATION; EVIDENCE BASED MEDICINE; GRAFT PATENCY; HEART INFARCTION; HUMAN; MEDICAL INFORMATION; MORTALITY; MYELODYSPLASTIC SYNDROME; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUMP; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SAFETY; SURVIVAL; THORAX SURGERY; THROMBOCYTE ANOMALY; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

EID: 20144388565     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.01.008     Document Type: Article

References (51)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
2. G.N. Levine, M.N. Ali, A.I. Schafer Antithrombotic therapy in patients with acute coronary syndromes Arch Intern Med 161 2001 937 948
3. V.A. Ferraris, S.P. Ferraris, O. Joseph, P. Wehner, R.M. Mentzer Jr Aspirin and postoperative bleeding after coronary artery bypass grafting Ann Surg 235 2002 820 827
4. Stein PD, Dalen JE, Goldman S, Schwartz L, Theroux P, Turpie AG. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1995;108:424S-30S.
5. Stein PD, Dalen JE, Goldman S, Theroux P. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1998;114:658S-65S.
6. J. van der Meer, H.L. Hillege, G.J. Kootstra Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet 342 1993 257 264
7. A. Williams, C.H. Hennekens The role of aspirin in cardiovascular diseases - forgotten benefits? Expert Opin Pharmacother 5 2004 109 115
8. W.C. Johnson, W.O. Williford Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study J Vasc Surg 35 2002 413 421
9. D.P. Taggart, A. Siddiqui, D.J. Wheatley Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements Ann Thorac Surg 50 1990 424 428
10. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
11. A.K. Srinivasan, A.D. Grayson, D.M. Pullan, B.M. Fabri, W.C. Dihmis Effect of preoperative aspirin use in off-pump coronary artery bypass operations Ann Thorac Surg 76 2003 41 45
12. V.A. Ferraris, E. Swanson Aspirin usage and perioperative blood loss in patients undergoing unexpected operations Surg Gynecol Obstet 156 1983 439 442
13. K. Matsuzaki, K. Matsui, N. Haraguchi, I. Nagano, H. Okabe, T. Asou Ischemic heart attacks following cessation of aspirin before coronary artery bypass surgery: a report of two cases Ann Thorac Cardiovasc Surg 5 1999 121 122
14. Matsuzaki K, Okabe H, Kajihara N, et al. [A prospective study on the timing of discontinuation of aspirin before coronary artery bypass grafting]. Nippon Kyobu Geka Gakkai Zasshi 1997;45:1710-4.
15. A. Salvioni, G.B. Perego, G. Marenzi, S. Galli, E. Assanelli, M.D. Guazzi Platelet activity in the early stage of acute myocardial infarction: relation to time of presentation, treatment with either tissue plasminogen activator or streptokinase and cyclooxygenase inhibition J Thromb Thrombolysis 5 1998 65 71
16. Anand SS, Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol 2003;41:62S-9S.
17. C.M. O'Connor, W.A. Gattis, A.S. Hellkamp Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS) Am J Cardiol 88 2001 541 546
18. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
19. J.T. Pang, S. Fort, A. Della Siega, E.A. Cohen Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use J Card Surg 17 2002 425 431
20. Lemmer JH. Jr. Clinical experience in coronary bypass surgery for abciximab-treated patients. Ann Thorac Surg 2000;70:S33-7.
21. C.M. Dyke, D. Bhatia, T.J. Lorenz Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy. Ann Thorac Surg 70 2000 866 872
22. J.H. Lemmer Jr, M.T. Metzdorff, A.H. Krause Jr, M.A. Martin, J.E. Okies, J.G. Hill Emergency coronary artery bypass graft surgery in abciximab-treated patients Ann Thorac Surg 69 2000 90 95
23. F. Bizzarri, S. Scolletta, E. Tucci Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting J Thorac Cardiovasc Surg 122 2001 1181 1185
24. N. Zimmermann, A. Wenk, U. Kim Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542 547
25. L. Macchi, L. Christiaens, S. Brabant Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms J Am Coll Cardiol 42 2003 1115 1119
26. C. Cerletti, G. Dell'Elba, S. Manarini Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes Clin Pharmacokinet 42 2003 1059 1070
27. P. Barragan, J.L. Bouvier, P.O. Roquebert Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation Catheter Cardiovasc Interv 59 2003 295 302
28. V.A. Ferraris, S.P. Ferraris, F.C. Lough, W.R. Berry Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting Ann Thorac Surg 45 1988 71 74
29. V.A. Ferraris, V. Gildengorin Predictors of excessive blood use after coronary artery bypass grafting A multivariate analysis [see comments] J Thorac Cardiovasc Surg 98 1989 492 497
30. V. Ferraris, S. Ferraris Limiting excessive postoperative blood transfusion after cardiac procedures: a review Tex Heart Inst J 22 1995 216 230
31. J. Alvarez, L. Jackson, C. Chatwin, J. Smolich Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial J Thorac Cardiovasc Surg 122 2001 457 463
32. A.J. Grau, S. Reiners, C. Lichy, F. Buggle, A. Ruf Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study Stroke 34 2003 849 854
33. A.I. Malinin, D. Atar, K.P. Callahan, M.E. McKenzie, V.L. Serebruany Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease Eur J Pharmacol 462 2003 139 143
34. M. Jenicek Foundations of evidence-based medicine 2002 Parthenon New York
35. S. Goldman, J. Copeland, T. Moritz Starting aspirin therapy after operation Effects on early graft patency Department of Veterans Affairs Cooperative Study Group. Circulation 84 1991 520 526
36. G.K. Sethi, J.G. Copeland, S. Goldman, T. Moritz, K. Zadina, W.G. Henderson Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy J Am Coll Cardiol 15 1990 15 20
37. S. Goldman, J. Copeland, T. Moritz Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study Circulation 77 1988 1324 1332
38. P. Kallis, J.A. Tooze, S. Talbot, D. Cowans, D.H. Bevan, T. Treasure Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina Eur J Cardiothorac Surg 8 1994 404 409
39. E.L. Michelson, J. Morganroth, M. Torosian, H. MacVaugh III Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery J Thorac Cardiovasc Surg 76 1978 694 697
40. M. Torosian, E.L. Michelson, J. Morganroth, H. MacVaugh III Aspirin- and coumadin-related bleeding after coronary-artery bypass graft surgery Ann Intern Med 89 1978 325 328
41. G. Bashein, M.L. Nessly, A.L. Rice, R.B. Counts, G.A. Misbach Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery Arch Intern Med 151 1991 89 93
42. D.L. Reich, G.C. Patel, F. Vela-Cantos, C. Bodian, S. Lansman Aspirin does not increase homologous blood requirements in elective coronary bypass surgery Anesth Analg 79 1994 4 8
43. S.V. Karwande, B.B. Weksler, W.A. Gay, V.A. Subramanian Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis Ann Thorac Surg 43 1987 318 322
44. K.J. Tuman, R.J. McCarthy, C.J. O'Connor, W.E. McCarthy, A.D. Ivankovich Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery Anesth Analg 83 1996 1178 1184
45. A. Vuylsteke, A. Oduro, E. Cardan, R.D. Latimer Effect of aspirin in coronary artery bypass grafting J Cardiothorac Vasc Anesthes 11 1997 831 834
46. L.J. Dacey, J.J. Munoz, E.R. Johnson Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients Ann Thorac Surg 70 2000 1986 1990
47. J.G. Ray, S. Deniz, A. Olivieri Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel BMC Cardiovasc Disord 3 2003 3
48. J.P. Schonberger, J.J. Bredee, W. van Oeveren Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin J Thorac Cardiovasc Surg 106 1993 262 267
49. R.E. Rawitscher, J.W. Jones, T.A. McCoy, D.A. Lindsley A prospective study of aspirin's effect on red blood cell loss in cardiac surgery J Cardiovasc Surg (Torino) 32 1991 1 7
50. S. Bjessmo, T. Ivert Blood loss after coronary artery bypass surgery: relations to patient variables and antithrombotic treatment Scand Cardiovasc J 34 2000 438 445
51. E. Braunwald, E.M. Antman, J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374